Literature DB >> 2778810

Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis.

M J Curtis1, D J Hearse.   

Abstract

The relationship between reperfusion-induced arrhythmias and the size of the occluded zone was examined. The isolated perfuse rat heart was used because its negligible collateral flow maximizes susceptibility to arrhythmias and reduces variability. Ischemia lasting 10 min was followed by 10 min of reperfusion. A constant-pressure perfusion system (which precludes coronary steal) permitted measurement of the rapidity of restoration of coronary flow. Mean occluded zone sizes of 0, 7.2 +/- 1.1, 19.5 +/- 1.5, 45.8 +/- 1.7, 30.1 +/- 4, and 100% of the total ventricular weight were obtained by sham ligation, distal, medial and proximal ligation of the left main coronary artery, right arterial ligation and the induction of global ischemia, respectively. Occluded zone size correlated positively (r = 0.86, P less than 0.001) with a linearly-additive arrhythmia score irrespective of the site of ischemia (left versus right ventricle). In globally ischemic hearts, ventricular fibrillation (VF) depended upon ventricular beating rate during ischemia, occurring only if the rate exceeded 150 beats/min. If this factor were taken into consideration, VF incidence exhibited a sigmoidal relationship with occluded zone size. During the first min of reperfusion, the rapidity of restoration of coronary flow was inversely related to occluded zone size (P less than 0.001) and had a small but significant effect on the severity of arrhythmias; slow recovery of flow increased susceptibility. We conclude that when reperfusion is elicited at the moment of peak susceptibility to arrhythmias, VF incidence is determined principally by occluded zone size. Heart rate during ischemia becomes relevant at rates less than 150 beats/min, when a protective effect is seen. Since VF incidence was 100% in hearts reperfused after global ischemia, an interface between non-ischemic tissue and reperfused tissue is therefore unnecessary for arrhythmogenesis during reperfusion, and flow of injury current between non-ischemic and reperfused tissue can be ruled out as a mechanism of arrhythmogenesis. The initiation of reperfusion-induced arrhythmias must therefore take place within the reperfused tissue.

Entities:  

Mesh:

Year:  1989        PMID: 2778810     DOI: 10.1016/0022-2828(89)90828-6

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

1.  Mitochondria, the calcium uniporter, and reperfusion-induced ventricular fibrillation.

Authors:  H Clements-Jewery
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

3.  Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.

Authors:  Hugh Clements-Jewery; Gajen Sunthar Kanaganayagam; Ruchi Kabra; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart.

Authors:  Gwo-Jyh Chang; Yung-Hsin Yeh; Tsung-Pin Lin; Chi-Jen Chang; Wei-Jan Chen
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

5.  Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways.

Authors:  Márton Pipicz; Zoltán V Varga; Krisztina Kupai; Renáta Gáspár; Gabriella F Kocsis; Csaba Csonka; Tamás Csont
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

6.  IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.

Authors:  J Chen; S Komori; B Li; K Tamura; K Hashimoto
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.

Authors:  A Farkas; A Qureshi; M J Curtis
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

9.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart.

Authors:  R Pabla; P Bland-Ward; P K Moore; M J Curtis
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.